semaglutide cardiac protection The Cardioprotective Effects of Exceed Those of Dietary Weight Loss in Mice With HFpEF semaglutide cardiac protection Semaglutide. Tirzepatide.

Because the dose and formulation are customized to your clinical needs and genetic profile, you have more control over how your body responds

You might NOT be able to take GLP-1 if you have a history of pancreatitis, kidney disease/kidney insufficiency, Stomach problems, diabetes (must be approved from endocrinologist) or gall bladder disease

Long-term maintenance therapy is usually necessary to sustain weight loss benefits

There are no NICE guidelines recommending genetic testing before starting obesity treatment

Fertility changes: Weight loss can sometimes improve ovulation, which might make pregnancy more likely